$RXMD Rallying Off Buy Signal at Key Support in Telehealth Space

OTC:RXMD   Progressive Care, Inc
RXMD has double-bottom key support lined up with a major MACD buy signal after breaking above its recent downtrend line in yesterday's action. This is a Coronavirus play at the leading edge in both telehealth and home pharmacy delivery.

• Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case growth.
RXMD is currently priced at 0.5x trailing sales, which is extremely cheap, even for a pharmacy play.
• This is especially true given that it just posted 56% top-line growth and is moving toward the likely launch of a telemedicine platform.
RXMD is moving toward a NASDAQ or NYSE uplisting.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.